BLOOMBERG: Expect Consolidation in Pharma, But Not From Merck: CEO

Merck Chairman of the Executive Board and CEO Karl-Ludwig Kley discusses his company’s acquisition of Sigma-Aldrich, consolidation in the Pharmaceuticals and the outlook for the sector. He speaks to Bloomberg’s Anna Edwards on “Countdown.”